Myogene Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- CureDuchenne Ventures announced funding for MyoGene Bio, LLC, a biotech company developing a novel gene editing therapy for Duchenne muscular...

Fifteen tech-enabled startups with at least one team member from an underrepresented demographic are sharing $198,000 in non-dilutive grant funding from Delaware’s third Startup302 competition, which was coordinated by Delaware Prosperity Partnership (DPP) and partners. This year, the competition

For UCLA-based startup, new muscular dystrophy treatment is a personal mission MyoGene Bio, a finalist in UC Startup Innovation Challenge, is developing a gene therapy for the deadly childhood condition UCLA Wayne Lewis | February 23, 2021 Courtney Young helped develop the gene therapy at the heart of a biotech startup, MyoGene Bio, when she was a doctoral student at UCLA from 2013 to 2018. But the kernel of the company’s endeavor is older still — and definitively personal. In 2008, when Young was in high school, she found out that her cousin, then just a toddler, had been diag...

A search-and-rescue robot from Squishy Robotics, one of the finalists in UC’s Startup Innovation Challenge. The University of California has selected 10 finalists for its 2021 Startup Innovation Challenge, held in partnership with Extreme Tech Challenge (XTC), the world’s largest tech-for-good startup competition. The chosen finalists are comprised of companies with game-changing ideas for fighting climate change, feeding the world, curing diseases and saving the day with robots that can be airdropped into disaster zones. The finalists will pitch their startups to investors at the Global ...